Expert commentary: The RISE study
With all three RISE studies now published, John Wilding reflects on the pathophysiological differences between children and adults with type 2 diabetes (2:12).
- News story | RISE adult medication results highlight disparity with youth with diabetes
- News story | TODAY2 confirms steep type 2 diabetes trajectory in youth
- News story | RISE: Early insulin does not slow beta cell decline in youth with type 2 diabetes
- Expert commentary | WATCH: Dana Dabelea discusses the results of the RISE pediatric study